Weston Nichols

Director, Crinetics Pharmaceuticals.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 1, 2026Returned to company 5,925 shares at $85.00 of Crinetics Pharmaceuticals²
Sep 1, 2026Returned to company 16,300 shares at $85.00 of Crinetics Pharmaceuticals²
Jun 25, 2026Bought 50,055 shares at $4.12 of Passage BIO, Inc.³
Jun 18, 2026Granted 5,925 shares of Crinetics Pharmaceuticals⁴
Mar 31, 2026Bought 520 shares at $10.60 of Korro Bio, Inc.⁵
Oct 28, 2025Bought 165,667 shares at $8.40 of Cullinan Oncology⁶
Sep 15, 2025Bought 11,900 shares at $6.99 of Passage BIO, Inc.⁷
Sep 12, 2025Bought 19,783 shares at $6.99 of Passage BIO, Inc.⁷
Sep 11, 2025Bought 325 shares at $6.96 of Passage BIO, Inc.⁷
Jun 11, 2025Granted 6,900 shares of Crinetics Pharmaceuticals⁸
Dec 13, 2024Bought 100,000 shares at $2.90 of TScan Therapeutics, Inc.⁹
Dec 12, 2024Bought 31,800 shares at $3.01 of TScan Therapeutics, Inc.⁹
Nov 15, 2024Bought 947 shares at $4.34 of TScan Therapeutics, Inc.¹⁰
Jun 7, 2024Granted 3,400 shares of Crinetics Pharmaceuticals¹¹
Jun 16, 2023Granted 6,000 shares of Crinetics Pharmaceuticals¹²

The numbers on this page point here. Each one links to the record it came from.